Indhold
- EN English
Strategic inquiry into pre‐submission activities organised by the European Medicines Agency (OI/7/2017/KR).
Åbne sager
Sag OI/7/2017/KR - Indledt den Mandag | 17 juli 2017 - Afgørelse af Onsdag | 17 juli 2019 - Den vedrørte institution Det Europæiske Lægemiddelagentur ( Ikke grund til yderligere undersøgelser ) - Land Frankrig
The European Ombudsman, Emily O'Reilly, has opened an inquiry into the pre-submission activities that the European Medicines Agency (EMA) offers to individual medicine developers before the Agency receives applications for marketing authorisations from them.
Relaterede dokumenter
Sag OI/7/2017/KR
- Tirsdag | 26 november 2019Beskrivelse af sagen
Ombudsman inquiry strengthens transparency and objectivity of EMA's assessment of new medicines
- Tirsdag | 26 november 2019Afgørelse
- Onsdag | 26 juni 2019Inspektionsrapport
- Onsdag | 26 juni 2019Inspektionsrapport
- Mandag | 08 oktober 2018Åben høring
- Tirsdag | 19 december 2017Inspektionsrapport
- Torsdag | 21 november 2019Korrespondance
- Fredag | 03 maj 2019Korrespondance
- Tirsdag | 05 februar 2019Korrespondance
Submission to the consultation from the Main Association of Austrian Social Security Institutions
- Tirsdag | 05 februar 2019Korrespondance
Submission to the consultation from the International Society of Drug Bulletins
- Tirsdag | 05 februar 2019Korrespondance
- Tirsdag | 05 februar 2019Korrespondance
Submission to the consultation from the Federation of Veterinarians of Europe
- Tirsdag | 05 februar 2019Korrespondance
Submission to the consultation from the Norwegian Medicines Agency
- Tirsdag | 05 februar 2019Korrespondance
Submission to the consultation from the Medicines Evaluation Board of the Netherlands
- Tirsdag | 05 februar 2019Korrespondance
Submission to the consultation from the European Patients’ Forum
- Tirsdag | 05 februar 2019Korrespondance
Submission to the consultation from FIMEA, the Finnish Medicines Agency
- Tirsdag | 05 februar 2019Korrespondance
Submission to the consultation from the European Public Health Alliance (EPHA)
- Tirsdag | 05 februar 2019Korrespondance
Submission to the consultation from the French Agency for Veterinary Medicinal Products
- Tirsdag | 05 februar 2019Korrespondance
Submission to the consultation from the Danish Medicines Agency
- Tirsdag | 05 februar 2019Korrespondance
Submission to the consultation from the European Organisation for Rare Diseases (Eurordis)
- Tirsdag | 05 februar 2019Korrespondance
Submission to the consultation from Health Action International
- Tirsdag | 05 februar 2019Korrespondance
- Mandag | 04 februar 2019Korrespondance
Submission to the consultation from the German Pharmaceutical Industry Association
- Mandag | 04 februar 2019Korrespondance
Submission to the consultation from the National Institute for Health and Care Excellence, UK
- Mandag | 04 februar 2019Korrespondance
Submission to the consultation from the Austrian Medicines and Medical Devices Agency
- Mandag | 04 februar 2019Korrespondance
Submission to the consultation from BEUC, European Consumer Organization
- Mandag | 04 februar 2019Korrespondance
Submission to the consultation from the Swedish Medical Products Agency
- Mandag | 04 februar 2019Korrespondance
Submission to the consultation from the Institute for Quality and Efficiency in Health Care (IQWiG)
- Mandag | 04 februar 2019Korrespondance
- Mandag | 04 februar 2019Korrespondance
- Mandag | 04 februar 2019Korrespondance
Submission to the consultation from the European Social Insurance Platform
- Mandag | 04 februar 2019Korrespondance
Submission to the consultation from the Standing Committee of European Doctors
- Mandag | 04 februar 2019Korrespondance
- Fredag | 01 februar 2019Korrespondance
Submission to the consultation from the Heads of Medicines Agencies (HMA)
- Torsdag | 31 januar 2019Korrespondance
- Torsdag | 31 januar 2019Korrespondance
Submission to the consultation from the European Association for Bioindustries, EuropaBio
- Onsdag | 30 januar 2019Korrespondance
- Tirsdag | 22 januar 2019Korrespondance
Submission to the consultation from Ludwig Boltzmann Institute for Health Technology Assessment
- Tirsdag | 22 januar 2019Korrespondance
Submission to the consultation from the German Association of Statutory Health Insurance Funds
- Tirsdag | 22 januar 2019Korrespondance
- Tirsdag | 22 januar 2019Korrespondance
Submission to the consultation from Fondazione Telethon / Istituto San Raffaele Telethon
- Onsdag | 16 januar 2019Korrespondance
Submission to the consultation from the European Forum for Primary Care
- Søndag | 13 januar 2019Korrespondance
- Torsdag | 10 januar 2019Korrespondance
- Torsdag | 20 december 2018Korrespondance
- Tirsdag | 18 december 2018Korrespondance
Submission to the consultation from the Association of European Cancer Leagues (ECL)
- Torsdag | 31 august 2017Korrespondance
- Mandag | 17 juli 2017Korrespondance